Leigh Anne Eller - Concepedia

Author

Leigh Anne Eller

Also Known As

Eller, Leigh Anne, Kibuuka, Hannah, Kim, Jerome H., Kimberly Bohince, L Eller, L. A. Eller, Lara Martins Eller, Leigh Anne Eller, Leigh A Eller, Leigh A. Eller

146

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Henry M. Jackson Foundation Walter Reed Army Institute of Research Makerere University Walter Reed Project National Institute of Allergy and Infectious Diseases Armed Forces Research Institute of Medical Science

About

Leigh Anne Eller is an author at Henry M. Jackson Foundation specializing in medicine, immunology, and hiv.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.9K
2	Public Health	4	4	94
3	Natural Sciences	3	3	106
4	Allergy	3	3	337
5	Biomolecular Engineering	1	1	23

Leigh Anne Eller

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox Patricia L. Earl, Jeffrey L. Americo, Linda S. Wyatt, Nature VaccinationVaccine DevelopmentVaccine ResearchVaccine TargetImmunology	2004	457
Protective Efficacy of a Global HIV-1 Mosaic Vaccine against Heterologous SHIV Challenges in Rhesus Monkeys Dan H. Barouch, Kathryn E. Stephenson, Erica N. Borducchi, Cell VaccinationProtective EfficacyVaccine DevelopmentHeterologous Shiv ChallengesRhesus Monkeys	2013	337
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand Merlin L. Robb, Leigh Anne Eller, Hannah Kibuuka, New England Journal of Medicine	2016	281
Effect of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV‐1 Infection Noah Kiwanuka, Oliver Laeyendecker, Merlin L. Robb, The Journal of Infectious Diseases	2008	270
Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge Linda S. Wyatt, Patricia L. Earl, Leigh Anne Eller, Proceedings of the National Academy of Sciences VaccinationVaccinologyMucosal VaccinationVaccine DevelopmentAllergy	2004	249
Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study Danielle V. Clark, Hannah Kibuuka, Monica Millard, The Lancet Infectious Diseases Virus EpidemiologyLong-term SequelaeDisease OutbreakDisease TransmissionEmerging Infectious Disease	2015	225
Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial Hannah Kibuuka, Nina M. Berkowitz, Monica Millard, The Lancet VaccinologyVaccine SafetyVaccinationPhase 1BVaccine Development	2014	125
A Phase 1/2 Study of a Multiclade HIV‐1 DNA Plasmid Prime and Recombinant Adenovirus Serotype 5 Boost Vaccine in HIV‐Uninfected East Africans (RV 172) Hannah Kibuuka, Robert Kimutai, Leonard Maboko, The Journal of Infectious Diseases	2010	105
Multi-omics analyses reveal that HIV-1 alters CD4+ T cell immunometabolism to fuel virus replication Haitao Guo, Qi Wang, Khader Ghneim, Nature Immunology Virus ReplicationViral ReplicationHuman RetrovirusImmunologyAntiviral Response	2021	103
HIV-1 Viral Subtype Differences in the Rate of CD4+ T-Cell Decline Among HIV Seroincident Antiretroviral Naive Persons in Rakai District, Uganda Noah Kiwanuka, Merlin L. Robb, Oliver Laeyendecker, JAIDS Journal of Acquired Immune Deficiency Syndromes	2010	102

Page 1